[DOI] [PubMed] [Google Scholar] Lokrantz CM, Eriksson B, Rosen I, Asztely F
Patients typically begin on a lower introductory dose to allow the body to adjust comfortably, which our Allen-based providers then gradually increase over time based on your individual progress and tolerance
The study received funding from Wellcome, Medical Research Council, European Union Horizon 2020 Programme, the National Institutes of Health (grants U01-DK105535, U01-DK085545 and UM-1DK126185), the National Institute for Health Research Oxford Biomedical Research Centre, the Canadian Institutes of Health Research, the Novo Nordisk Foundation, Boehringer Ingelheim and Diabetes Australia.
Share this article and the accompanying checklists with someone who is using a GLP-1 medication, considering medical weight management, or helping patients navigate substantial weight loss